INFECT-NL is a partnership between five leading Dutch institutions: the Leiden University Medical Centre (LUMC), Radboudumc, Amsterdam UMC, UMC Utrecht and the Centre for Human Drug Research (CHDR). Coordinated by FAST, they will join forces for early clinical research into new treatments and vaccines, creating a hub within which collaboration and knowledge sharing will be fostered. INFECT-NL will build a facility where early phase clinical trials and controlled infection studies can take place with new drugs and vaccines against infectious diseases. The facility will provide a dedicated space, separated from other healthcare facilities, where research can be conducted, including during pandemics. This separation ensures that crucial research can continue without disrupting the routine of daily healthcare.